Smad-WNT crosstalk in renal dysplasia

Information

  • Research Project
  • 9654744
  • ApplicationId
    9654744
  • Core Project Number
    F31DK112602
  • Full Project Number
    5F31DK112602-03
  • Serial Number
    112602
  • FOA Number
    PA-16-309
  • Sub Project Id
  • Project Start Date
    3/1/2017 - 8 years ago
  • Project End Date
    2/29/2020 - 5 years ago
  • Program Officer Name
    MARIC-BILKAN, CHRISTINE
  • Budget Start Date
    3/1/2019 - 6 years ago
  • Budget End Date
    2/29/2020 - 5 years ago
  • Fiscal Year
    2019
  • Support Year
    03
  • Suffix
  • Award Notice Date
    2/1/2019 - 6 years ago
Organizations

Smad-WNT crosstalk in renal dysplasia

Abstract Congenital anomalies of the kidney and urinary tract (CAKUT) are the primary cause of juvenile chronic kidney disease (CKD). There is no cure for CKD and progression of the disease can lead to end stage renal failure. A stronger understanding of the mechanisms that control normal kidney organogenesis will help in the design of therapeutics to treat CKD. TGF?/BMP signaling through Smads plays a pivitol role in renal fibrosis but the function of this pathway in interstitial cells during kidney development is poorly understood. Preliminary data presented in this application shows that loss of Smad4 in renal interstitial cell progenitors results in unrestricted proliferation and expansion of the medullary interstitium in postnatal mice. WNT/?-catenin drives interstitial proliferation in vivo and marker analysis shows that the loss of proliferation control observed in Smad4- deficient mice is associated with increased LEF1 expression. Therefore, Smad signaling and WNT/?- catenin/LEF1 may play opposing roles in regulating proliferation of renal interstitial cells during postnatal development. The proposed research strategy will 1) define the mechanism by which Smad4 suppresses proliferation of interstitial cells in vitro and 2) determine if BMP signaling through Smads antagonizes WNT-induced proliferation in the postnatal medullary interstitium in vivo. Through a combination of thoughtful mentoring, rigorous scientific investigation using novel methods of primary cell isolation and 3- dimensional tissue analyses, participation in technical workshops and scientific meetings, practice in manuscript and grant preparation, and an ongoing education in research ethics, the proposed training plan will prepare the applicant for a successful independent career in biomedical research.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    F31
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
    29902
  • Indirect Cost Amount
  • Total Cost
    29902
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:29902\
  • Funding Mechanism
    TRAINING, INDIVIDUAL
  • Study Section
    ZDK1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MAINE MEDICAL CENTER
  • Organization Department
  • Organization DUNS
    071732663
  • Organization City
    PORTLAND
  • Organization State
    ME
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    041023175
  • Organization District
    UNITED STATES